About Sarah Krüg


Sarah Krüg is a researcher, innovator, and patient advocate, whose mission is to alleviate health disparities and amplify the voices of patients and caregivers across healthcare. She is CEO of CANCER101, a patient advocacy organization whose mission is to help patients and caregivers navigate the cancer journey and partner with their healthcare team to make informed decisions. Sarah is also the founder of the Health Collaboratory, an innovations hub focused on amplifying the voice of the patient and bridging the gaps in healthcare. She is the acting Executive Director and Past President of the Society for Participatory Medicine, and serves on the board of the National Organization of Rare Diseases. She previously held the position of Global Education Director at Pfizer, as well as patient advocacy relations, where she also established the Global Investigator Initiated Research Program. Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan- Kettering Cancer Center.